2025
Pregnant Patient for Non-Obstetric Surgery
Salimi N, Fardelmann K. Pregnant Patient for Non-Obstetric Surgery. 2025, 345-357. DOI: 10.1093/med/9780190902001.003.0031.Peer-Reviewed Original ResearchNon-obstetric surgeryPregnant patientsFetal outcomesAdverse fetal outcomesFetal morbidityGestational ageNon-obstetricSurgeryNeurocognitive developmentOrthopedic proceduresAnesthetic exposurePatientsAnesthetic agentsMultidisciplinary approachPregnancyDelayed careOutcomesNeonatologyObstetricsMorbidityTeratogenicityAnesthesiaMedicationMortalityEthical principles
2024
COVID-19 in pregnancy: Perinatal outcomes and complications
Akinosoglou K, Schinas G, Papageorgiou E, Karampitsakos T, Dimakopoulou V, Polyzou E, Tzouvelekis A, Marangos M, Papageorgiou D, Spernovasilis N, Adonakis G. COVID-19 in pregnancy: Perinatal outcomes and complications. World Journal Of Virology 2024, 13: 96573. PMID: 39722762, PMCID: PMC11551681, DOI: 10.5501/wjv.v13.i4.96573.Peer-Reviewed Original ResearchNeonatal intensive care unitIntensive care unitPregnant womenPerinatal outcomesGestational agePredictor of adverse fetal outcomesPregnant COVID-19 patientsOutcomes of pregnant womenCare unitAdverse fetal outcomesED presentationsPreterm delivery rateUnfavorable perinatal outcomesEmergency departmentRisk of severe coronavirus disease 2019Severe coronavirus disease 2019Invasive mechanical ventilationDelayed ED presentationsPredictors of hospitalizationFetal outcomesPreterm deliveryPerinatal morbidityCOVID-19 patientsClinical characteristicsTreatment modalities
2022
Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age
Hsu FI, Lumry W, Riedl M, Tachdjian R. Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age. Allergy, Asthma & Clinical Immunology 2022, 18: 64. PMID: 35831891, PMCID: PMC9281160, DOI: 10.1186/s13223-022-00689-9.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsHereditary angioedemaHealth statusAdverse fetal outcomesCohort of patientsChoice of therapyContinuity of careMedical Advisory BoardC1-INH deficiencyWomen's health statusRisk-benefit assessmentHAE attacksHAE managementFetal outcomesProphylactic therapyPatient populationTreatment optionsFemale sexDisease burdenTreatment decisionsContraceptive useUnpredictable episodesTreatment efficacyMucous membranesGynecologic specialistsPregnancy
2018
Type I interferons instigate fetal demise after Zika virus infection
Yockey LJ, Jurado KA, Arora N, Millet A, Rakib T, Milano KM, Hastings AK, Fikrig E, Kong Y, Horvath TL, Weatherbee S, Kliman HJ, Coyne CB, Iwasaki A. Type I interferons instigate fetal demise after Zika virus infection. Science Immunology 2018, 3 PMID: 29305462, PMCID: PMC6049088, DOI: 10.1126/sciimmunol.aao1680.Peer-Reviewed Original ResearchConceptsZika virus infectionZIKV infectionI IFNsI interferonType I interferonGrowth restrictionFetal demiseVirus infectionSevere fetal growth restrictionType I IFNsChorionic villous explantsAdverse fetal outcomesCongenital viral infectionFetal growth restrictionMaternal-fetal barrierType IFunctional type IPlacental damageFetal outcomesPregnancy complicationsEarly pregnancyFetal resorptionZIKV diseasePregnant damsSpontaneous abortion
2007
Cell Type-specific Expression and Function of Toll-like Receptors 2 and 4 in Human Placenta: Implications in Fetal Infection
Ma Y, Krikun G, Abrahams VM, Mor G, Guller S. Cell Type-specific Expression and Function of Toll-like Receptors 2 and 4 in Human Placenta: Implications in Fetal Infection. Placenta 2007, 28: 1024-1031. PMID: 17588655, PMCID: PMC2064901, DOI: 10.1016/j.placenta.2007.05.003.Peer-Reviewed Original ResearchConceptsInnate immune responseIL-8 levelsToll-like receptorsTLR-4Immune responseTLR-2TLR functionTerm placentaToll-like receptor 2Endothelial cellsAdverse fetal outcomesTLR-2 expressionMaternal-fetal interfacePathogen-associated molecular patternsHuman term placentaCell type-specific expressionGram-negative bacterial lipopolysaccharideFetal outcomesPlacental infectionTLR expressionFetal infectionLPS treatmentMajor cell typesImmunohistochemical analysisStem villi
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply